Organon & Co.

OGN

Market Cap$4.77B

Close$

Compare Organon

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Organon & Co.	4.7	5.88%	-1461%	0.8	-125.1
Market Avg	59	1.3%	30%	-	1
Healthcare Avg	64.4	1.34%	15%	-	0.9

$38.29

Current Fair Value

106.4% upside

Undervalued by 106.4% based on the discounted cash flow analysis.

Share Statistics

Market cap	$4.77 Billion
Enterprise Value	$12.84 Billion
Dividend Yield	$1.0905 (5.88%)
Earnings per Share	$3.99
Beta	0.0
Outstanding Shares	257,172,661
Avg 30 Day Volume	2,099,330

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	4.66
PEG	1.15
Price to Sales	0.77
Price to Book Ratio	-18.55
Enterprise Value to Revenue	2.05
Enterprise Value to EBIT	9.67
Enterprise Value to Net Income	12
Total Debt to Enterprise	0.68
Debt to Equity	-125.14

Revenue Sources

No data

ESG Score

No data

About Organon & Co.